# Irinotecan Discontinuation and Reintroduction for Advanced Colorectal Cancer

> **NCT00320320** · PHASE2 · TERMINATED · sponsor: **Gachon University Gil Medical Center** · enrollment: 72 (—)

## Conditions studied

- Colorectal Neoplasms
- Metastases

## Interventions

- **DRUG:** Irinotecan

## Key facts

- **NCT ID:** NCT00320320
- **Lead sponsor:** Gachon University Gil Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-04
- **Primary completion:** 2007-04
- **Final completion:** 2007-04
- **Target enrollment:** 72 (—)
- **Why stopped:** Poor accrual
- **Last updated:** 2008-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00320320

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00320320, "Irinotecan Discontinuation and Reintroduction for Advanced Colorectal Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00320320. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*